Mercury Bio Launches MB-TIP™--Revolutionizing Immunotherapy with Intracellular Targeting
PR Newswire —
SANTA FE, N.M., Jan. 8, 2026 /PRNewswire/ -- Mercury Bio Inc. , an immunology-driven biotechnology company developing intracellular therapies for neurodegenerative diseases such as Alzheimer's and Parkinson's, today announced MB-TIP™ (Mercury Bio - Targeting Intracellular Pathologies)...